FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2022/08/045099 [Registered on: 30/08/2022] Trial Registered Prospectively
Last Modified On: 27/01/2023
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Dentistry 
Study Design  Other 
Public Title of Study   A clinical trial to evaluate the effect of laser assisted therapy using indocyanine green dye on bacterial infection levels in patients with gum disease. 
Scientific Title of Study   Effectiveness of photodynamic therapy using indocyanine green on microbial and procalcitonin levels in periodontitis patients - A comparative split mouth randomized controlled clinical trial 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Arya Anil 
Designation  POST GRADUATE STUDENT 
Affiliation  Rajiv Gandhi University of Health Sciences 
Address  Room no.5, Department of Periodontology, Bangalore institute of dental sciences and hospital, bengaluru

Bangalore
KARNATAKA
560029
India 
Phone  08921523418  
Fax    
Email  aryaanil018@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr S Sri Rangarajan 
Designation  HEAD OF THE DEPARTMENT , PERIODONTOLOGY 
Affiliation  Rajiv gandhi university and health sciences 
Address  Bangalore institute of dental sciences and hospital

Bangalore
KARNATAKA
560029
India 
Phone  9844282297  
Fax    
Email  docranga@yahoo.com  
 
Details of Contact Person
Public Query
 
Name  Dr Arya Anil 
Designation  POST GRADUATE STUDENT 
Affiliation  Rajiv Gandhi University of Health Sciences 
Address  Room no.5 , Department of Periodontology ,Bangalore institute of dental sciences and hospital, Bengaluru

Bangalore
KARNATAKA
560029
India 
Phone  08921523418  
Fax    
Email  aryaanil018@gmail.com  
 
Source of Monetary or Material Support  
Bangalore Institute of Dental Sciences and Hospital 
 
Primary Sponsor  
Name  Bangalore Institute of Dental Sciences and Hospital 
Address  Hosur main road , Lakkasandra , Wilson garden , Bengaluru , Karnataka 
Type of Sponsor  Private hospital/clinic 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Arya Anil  Bangalore institute of dental sciences and hospital  Room no . 5 , Department of Periodontology, Hosur main road , Lakkasandra , Wilson garden, Bengaluru, Karnataka
Bangalore
KARNATAKA 
08921523418

aryaanil018@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
instituitional ethical clearance committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: K053||Chronic periodontitis,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  SRP  SUPRA AND SUBGINGIVAL SCALING AND ROOT PLANING DONE WITH HAND SCALING INSTRUMENTS AND ULTRASONIC SCALERS 
Intervention  SRP AND LASER   SUPRA AND SUBGINGIVAL SCALING ADN ROOT PLANING DONE USING HAND AND ULTRASONIC SCALING INSTRUMENTS AFTER WHICH 810 nm LASER IS USED FOR IRRADIATING THE SELECTED PERIODONTAL POCKET FOR 60 SECONDS 
Intervention  SRP AND PHOTODYNAMIC THERAPY USING INDOCYANINE GREEN DYE  SUPRA AND SUBGINGIVAL SCALING AND ROOT PLANING DONE USING HAND AND ULTRASONIC SCALING INSTRUMENTS AFTER WHICH INDOCYANINE GREEN DYE IS APPLIED WITHIN THE SELECTED PERIODONTAL POCKET FOR 30 SECONDS FOLLOWED BY IRRADIATION WITH 810 nm DIODE LASER FOR 60 SECONDS 
 
Inclusion Criteria  
Age From  25.00 Year(s)
Age To  55.00 Year(s)
Gender  Both 
Details  1.patients with minimum 20 teeth present in the oral cavity .
2. periodontal pocket depth 5-6mm in minimal 3 sites ( one in each quadrant ) 
 
ExclusionCriteria 
Details  1.smokers
2.3rd molars
3.patients who have undergone periodontal therapy in last 6 months.
4.patients who have received antibiotic therapy in previous 3 months.
5.medically compromised patients
6.patients with known history of allergy
7.pregnant and lactating women 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   An Open list of random numbers 
Blinding/Masking   Participant and Investigator Blinded 
Primary Outcome  
Outcome  TimePoints 
1.compare and assess the microbial and biochemical parameters like BAPNA analysis on subgingival plaque samples and ELISA on GCF samples among SRP , SRP AND LASER , SRP AND PHOTODYNAMIC THERAPY groups in periodontitis patients  0 and 3 months 
 
Secondary Outcome  
Outcome  TimePoints 
to assess the clinical parameters like plaque index, gingival index, probing pocket depths , clinical attachment level and relative attachment level in periodontitis patients  0 and 3 months 
 
Target Sample Size   Total Sample Size="22"
Sample Size from India="22" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3 
Date of First Enrollment (India)   02/09/2022 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="3"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Yet Recruiting 
Recruitment Status of Trial (India)  Open to Recruitment 
Publication Details   none yet 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - YES
  1. What data in particular will be shared?
    Response - Individual participant data that underlie the results reported in this article, after de-identification (text, tables, figures, and appendices).

  2. What additional supporting information will be shared?
    Response -  Study Protocol
    Response - Clinical Study Report

  3. Who will be able to view these files?
    Response - Researchers whose proposed use of the data has been approved by an independent review committee identified for this purpose.

  4. For what types of analyses will this data be available?
    Response - To achieve aims in the approved proposal.

  5. By what mechanism will data be made available?
    Response - Proposals should be directed to [draryaanils21@gmail.com].

  6. For how long will this data be available start date provided 16-10-2023 and end date provided 16-10-2026?
    Response - Beginning 9 months and ending 36 months following article publication.

  7. Any URL or additional information regarding plan/policy for sharing IPD? 
    Additional Information - NIL
Brief Summary   Antimicrobial photodynamic therapy is being widely used in different therapeutic procedures in dentistry and medicine.’ Red complex bacteria have been seen to play a major role in controlling the biofilm in deep periodontal pockets thus having a major role in both initiation and progression of pocket depth. Indocyanine Green (ICG) offers the advantage of being active in deep pockets where these red complex bacteria’sthrive. ICG has demonstrated promising results in vitro studies specifically targeting the red complex periopathogens.Very limited studies have been done to evaluate the effect of PDT using ICG in-vivo. Serum procalcitonin is a potent marker for bacterial infections in the field of medicine. Recent articles suggest the utility of using GCF Procalcitonin levels as a marker for not just periodontal disease activity but also as an indicator for microbial activity.Hence, this novel study is designed to evaluate the effectiveness of diode laser and indocyanine green mediated photodynamic therapy as an adjunct to scaling and root planing on the red complex microflora and associated changes in GCF Procalcitonin levels in periodontitis patients. The additional microbial testing will help strengthen the decision making which was earlier based on clinical and inflammatory markers alone.
 
Close